Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
Published on February 26, 2025
Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy. The company's strong financial performance, innovative pipeline of drugs, and commitment to research and development have positioned it well in the competitive pharmaceutical industry. Investors seeking long-term growth potential can consider adding Amgen to their portfolio. For a professional forecast of Amgen's stock movement, consult experts at Stocks Prognosis.
Investor opinions & comments
To leave a comment, you need to Login or Register.
MarketMegan
March 1, 2025 at 19:50
Amgen's strong position in the pharmaceutical industry and their focus on innovation make them a compelling investment choice
FinanceFelix
March 1, 2025 at 19:49
I believe Amgen has a promising future in the pharmaceutical sector. Their research and development efforts can lead to significant breakthroughs
CharlotteCampbell
March 1, 2025 at 16:05
I've been following Amgen for a while and I'm excited about their potential. Their commitment to research and development is a key factor for me
InvestorIvy
March 1, 2025 at 13:09
I'm confident in Amgen's ability to deliver strong financial performance and I believe their innovative pipeline will drive future growth
RiskyRachel
March 1, 2025 at 10:52
Amgen's commitment to research and development is impressive. I think they have a lot of potential for growth
KatherineSanchez
March 1, 2025 at 09:44
I've been researching Amgen and I'm impressed with their financial performance. It seems like a good investment opportunity
FinanceFinn
March 1, 2025 at 02:07
Amgen's financial performance and dedication to research and development make it an attractive investment in the pharmaceutical industry
MoneyMabel
February 28, 2025 at 23:11
I've heard good things about Amgen's innovative pipeline of drugs. I think it could be a smart investment
PennyInvestor
February 28, 2025 at 10:49
I've been keeping an eye on Amgen and I think it's a solid investment choice. Excited to see its future growth
SaraBrown
February 28, 2025 at 08:38
Amgen's stock looks promising, especially considering their strong financial performance and innovative drug pipeline
SavingsSandy
February 28, 2025 at 02:57
I'm unsure about Amgen's ability to stay ahead in the competitive pharmaceutical industry. It might be too risky for my investment portfolio
NoraJenkins
February 27, 2025 at 21:17
I'm interested in adding Amgen to my portfolio. Their strong financial performance and innovative pipeline make them an attractive investment
JamesThomas
February 27, 2025 at 20:04
Amgen has a solid track record and their commitment to research and development sets them apart. It's definitely a stock to consider
WealthyWalter
February 27, 2025 at 20:01
Amgen is a strong company with a bright future. Investing in their stock could be a smart move
KatherineSanchez
February 27, 2025 at 10:44
Amgen's stock has great potential for long-term growth. It's definitely worth considering for my portfolio
HannahCarter
February 27, 2025 at 02:45
I agree with the analysts' assessment. Amgen's strong financials and focus on research and development make it an attractive investment in the pharmaceutical industry
SavingsSarah
February 26, 2025 at 18:48
Amgen's commitment to research and development is commendable. I think they have a bright future in the pharmaceutical industry
CashClaire
February 26, 2025 at 16:16
I've been looking to invest in pharmaceutical stocks and Amgen seems like a great option, especially with their strong financial performance and commitment to research and development
DividendDiane
February 26, 2025 at 13:12
I'm not convinced about Amgen's long-term growth potential. The pharmaceutical industry is highly competitive and there are many other options to consider
GrowthGreg
February 26, 2025 at 12:27
I think Amgen is a smart investment choice. Their dedication to research and development sets them apart in the pharmaceutical industry
TylerGonzalez
February 26, 2025 at 05:13
While Amgen seems interesting, I'm concerned about the volatility of the pharmaceutical industry. I'll need to do more research before considering it